Gynecologic Cancer News

An artificial intelligence model appeared to predict the likelihood of unplanned hospitalizations during chemoradiation therapy among a cohort of patients with various cancer types.

Assessment of sexual function occurred far less often among women undergoing brachytherapy for cervical cancer than men who received the internal radiotherapy for prostate cancer, according to results of a retrospective analysis.

GENEVA — Remote interventions led to higher screening rates for breast, cervical and colorectal cancers among women who live in rural areas, according to study results presented at World Cancer Congress.

Use of chemical hair-straightening products appeared associated with higher risk for uterine cancer among women in the prospective Sister Study cohort, according to data published in JNCI: Journal of the National Cancer Institute.

Paula M. Fracasso, MD, PhD, FACP, has been appointed deputy director of VCU Massey Cancer Center.

The abortion debate in the United States can be viewed through many lenses.

Parker Institute for Cancer Immunotherapy added Dana-Farber Cancer Institute and Gladstone Institutes to its immuno-oncology research partnership network.

U.S. counties considered more socioeconomically vulnerable had cancer screening rates below federally recommended guidelines, according to study results published in JAMA Network Open.

Medicaid expansion appeared associated with reductions in metastatic cancer incidence and overall cancer mortality, according to study results scheduled for presentation at ASCO Quality Care Symposium.

The FDA approved bevacizumab-adcd for treatment of six cancer types, according to a press release from the biosimilar’s manufacturer.